SEC Form 4 · accession 0000891293-15-000009

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Corporate Development

Period of report

Mar 4, 2015

Accepted (ET)

Mar 6, 2015 · 5:12 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000891293

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 4, 2015	S	1,200	$2.39	D	858,023	D
Common Stock	Mar 4, 2015	S	1,100	$2.395	D	856,923	D
Common Stock	Mar 4, 2015	S	1,800	$2.40	D	855,123	D
Common Stock	Mar 4, 2015	S	1,000	$2.405	D	854,123	D
Common Stock	Mar 4, 2015	S	1,700	$2.41	D	852,423	D
Common Stock	Mar 4, 2015	S	300	$2.415	D	852,123	D
Common Stock	Mar 4, 2015	S	2,800	$2.42	D	849,323	D
Common Stock	Mar 4, 2015	S	200	$2.425	D	849,123	D
Common Stock	Mar 4, 2015	S	600	$2.43	D	848,523	D
Common Stock	Mar 4, 2015	S	200	$2.435	D	848,323	D
Common Stock	Mar 4, 2015	S	1,100	$2.44	D	847,223	D

No Table II lines on this filing.